210 results about "Drug quality" patented technology

The invention relates to the technical field of cold-chain medicine transportation, in particular to an intelligent monitoring and early warning system for a cold-chain medicine transportation environment. Comprising a multi-source heterogeneous data acquisition module, a time-space synchronization data fusion module, a three-dimensional thermodynamic distribution modeling module, a drug property degradation risk assessment module, a dynamic grading early warning module and a path self-optimization execution module, the multi-source heterogeneous data acquisition module is used for generating multi-source heterogeneous data; the space-time synchronization data fusion module generates an environment parameter matrix; the three-dimensional thermodynamic distribution modeling module calculates an equivalent thermal load value of each grid node; the drug property degradation risk assessment module predicts residual effective time; the dynamic grading early warning module generates a dynamic early warning signal; and the path self-optimization execution module generates optimized transportation path parameters. According to the invention, the medicine is prevented from losing efficacy due to environment change, and meanwhile, the response speed of cold-chain transportation and the medicine quality guarantee are improved.

The invention discloses a liquid medicine foreign matter detection method and system based on machine vision, and the method comprises the steps: obtaining multiband spectral data of a liquid medicine sample, and carrying out the normalization processing to generate a liquid medicine background standard spectral feature template; comparing the refractive index spectral characteristics of the template and the foreign matter-containing liquid medicine, and recording the surface roughness scattering mode and polarized light reflection angle change data of a foreign matter area; calculating a spectrum peak displacement quantized value according to the polarized light data, and extracting foreign matter edge spectrum gradient information in combination with a threshold value; calculating a transparency spectral attenuation coefficient based on the edge gradient information, and obtaining spectral contrast enhancement factors of different foreign matters in combination with the spectral response characteristic data; and if the enhancement factor does not reach the standard, adjusting the spectrum correction parameter and recalculating, fusing the scattering mode and the multi-angle incident spectrum response result to carry out consistency verification, and obtaining a final identification result containing the foreign matter material type and the danger level. The method can improve the drug detection accuracy and guarantee the drug quality safety.

The invention discloses a comprehensive detection method for detecting the quality of a traditional Chinese medicine capsule, and relates to the technical field of medicine quality detection.According to the method, the quality fluctuation of a shell can be effectively recognized by monitoring the elasticity modulus of the shell of the capsule in real time and constructing a variable coefficient; and secondly, further monitoring is carried out aiming at capsule filling types and density uniformity, so that the uniformity of medicine filling is ensured, the medicine effect fluctuation caused by non-uniform filling is avoided, and the release consistency of the medicine is improved. And then, based on dissolution rate gradient monitoring under different temperature and pH value conditions, the dissolution characteristics of the capsule in various environments can be comprehensively evaluated, so that the dissolution performance stability of the capsule is guaranteed. And finally, accurately calculating a dissolution stable factor by combining the detection of trace dissolution substances with a dissolution characteristic analysis model, and further optimizing the quality evaluation of the capsules by combining a dissolution rate change coefficient, thereby reducing unqualified batches caused by uneven dissolution.

The invention relates to a drug key quality attribute screening method based on serious adverse reaction data, and the method employs the serious adverse reaction data to establish appropriate indexes, and is used for dividing the serious adverse reaction risk levels of different products of the same variety. And a drug key quality attribute screening method based on the adverse reaction data is established from the overall perspective, and key control points of processes related to drugs are explored. The established method can prompt the possible correlation between the quality attribute of the medicine and the occurrence probability of the serious adverse reaction, and provides a direction for further carrying out toxicological research and medicine quality standard research; the method is not influenced by the selection range of quality attributes, only the internal relevance is searched in the existing range, and the result reliability is good; the correlation is used for replacing the causal relationship, the result of logistic regression reveals possible objective phenomena, a further toxicity evaluation direction is given, and the method has guiding significance and application value for improvement of a drug process and improvement of a drug standard.

The invention relates to the technical field of medicine management, and discloses a medicine informatization whole-process management system based on big data analysis. According to the system, a drug full-life-cycle multi-dimensional data stream is captured through a distributed sensing node network, and a drug state tensor is generated after noise filtering and missing value compensation are carried out through a real-time stream processing engine. The risk identification module scans and locates an abnormal data cluster through a multi-scale mode and constructs a drug quality hypersurface model; and the data aggregation module establishes a mapping relation between a state tensor and a quality model by using a space-time diagram attention network and calculates a global consistency metric value. The intelligent decision-making module generates an optimal drug management action sequence based on the measurement value under multiple constraint conditions, the closed-loop control module executes the action sequence and monitors system state deviation in real time, data acquisition parameters are dynamically calibrated, and autonomous optimization and closed-loop management of the whole process of drugs are achieved.

The invention provides a silibinin mixed micelle injection as well as a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations. The cholate / lecithin mixed micelle system constructed by adopting specific cholic acid and phospholipid has good stability, can be well compatible with the silibinin so as to well encapsulate the silibinin, can obviously improve the solubility of the silibinin, has higher safety under the condition of ensuring the stability of the silibinin, and can be used for preparing a medicine for treating the silibinin. Therefore, the bioavailability of the silibinin is greatly improved. According to the invention, a shearing dispersion method is adopted to prepare the mixed micelles, and the mixed micelles with high drug loading capacity, clarification and good stability for silibinin are formed by destroying and shearing the raw and auxiliary materials in a molecular level, so that the mixed micelles have better physical and chemical stability, the drug quality is easier to control, the process is more simplified, the clinical medication is safer and the cost is lower; and the accessibility of the medicine is improved.

The invention belongs to the technical field of analysis and detection of medicine related components, and particularly relates to a method for determining related substances of a methotrexate oral solution, the related substances comprise methotrexate impurity B, impurity C, impurity E, impurity D, impurity H and impurity I. The determination method adopts a high performance liquid chromatography method. A mobile phase of the high performance liquid chromatography comprises a mobile phase A and a mobile phase B, the mobile phase A is a buffer salt solution, the mobile phase B is acetonitrile, and gradient elution is adopted. According to the method, a plurality of known impurities in the methotrexate oral solution can be measured at the same time by utilizing the high performance liquid chromatography, interference generated by a blank solvent and an auxiliary material solution is eliminated, and the method can be used for accurately and quantitatively detecting related substances in the preparation process and the storage process of the methotrexate oral solution and serves as an important component for medicine quality control. The clinical use risk is reduced. The method is good in specificity, good in separation degree, good in accuracy and high in practicability in actual quality control work.

The invention provides a fingerprint spectrum and multi-component content determination method of a calamus-far nerve calming mixture, and relates to the field of quality control of traditional Chinese medicines. 31 common peaks are calibrated by establishing a fingerprint spectrum, and 24 common peaks can clearly belong to polygala tenuifolia. Meanwhile, synchronous content determination of seven components including chlorogenic acid, caffeic acid, ferulic acid, liquiritin, 2, 3, 5, 4 '-tetrahydroxy stilbene-2-O-beta-D-glucoside, 3, 6'-dimustard acyl sucrose and rosmarinic acid is realized. The method is good in precision, high in repeatability and stable and reliable in result, the medicine quality can be comprehensively and accurately reflected and controlled, and powerful support is provided for guaranteeing the safety and effectiveness of the calamus-far Ningmind mixture.

The invention provides a method for improving product quality by optimizing a posterior pituitary injection purification process, and belongs to the technical field of medicines. According to the method, glacial acetic acid is adopted as a dissolving medium, and the influence of the concentration of glacial acetic acid, the extraction temperature and the filtering condition on the posterior pituitary injection is investigated, so that visible foreign matters and macromolecular substances are effectively removed, and the potency, the specific activity and the potency ratio of the product are improved. Besides, the method is simple to operate, ensures the stability and curative effect of the product, is suitable for industrial production of the posterior pituitary injection, and has important significance for improving the drug quality and meeting clinical requirements.

The invention discloses a method for determining nitrosamine impurity N-nitrosociprofloxacin in ciprofloxacin lactate, and relates to the field of substance detection methods, the method adopts a liquid chromatography-mass spectrometry technology, and the liquid chromatography condition comprises that a mobile phase is a mixture of a formic acid solution with the concentration of 0.08%-0.12% and acetonitrile, and the volume ratio of the formic acid solution to the acetonitrile is (45-55): (45-55). According to the present invention, the liquid chromatography (LC) technology and the mass spectrometry (MS) technology are combined, such that the efficient separation ability of the liquid chromatography and the high sensitivity detection ability of the mass spectrometry are combined, the detection sensitivity and the detection accuracy are significantly improved, and the strict requirements of drug quality control and safety are met.

The invention relates to a heparin drug consistency evaluation method, system and device, and belongs to the technical field of drug quality control. Comprising the following steps: carrying out disaccharide analysis, oligosaccharide analysis and two-dimensional liquid phase analysis on a selected standard preparation to respectively obtain corresponding peak parameters, and constructing a qualitative database and a quantitative database according to the peak parameters; acquiring the chromatographic data of the reference preparation treated under the same condition as the sample to be detected, and performing consistency evaluation on the chromatographic data and the two databases; wherein the consistency evaluation comprises the following steps: acquiring chromatographic data of a reference preparation, performing automatic integration on the chromatographic data, and performing automatic attribution on components by utilizing a qualitative database to respectively obtain two peak contents; obtaining samples in a quantitative database; according to the sample, carrying out consistency evaluation on the two peak contents; and if yes, acquiring the chromatographic data of a large batch of samples to be detected and carrying out consistency evaluation on the chromatographic data. According to the method, the chromatographic data processing process is simplified, and the efficiency, accuracy and reliability of quality evaluation of the heparin drugs are improved.

The invention discloses a method for preparing an isavuconazole sulfate RS isomer impurity and a quaternary ammonium salt impurity, which comprises the following steps: taking SM1 and SM2 as starting materials, reacting in an ethyl acetate solvent, and preparing and separating after the reaction to obtain the RS isomer impurity and the quaternary ammonium salt impurity. The method for preparing the isavuconazole sulfate impurity is mild in reaction condition, simple to operate and high in product purity, does not need other harsh reaction conditions and high-pressure liquid phase preparation and other complex separation and purification means, and provides powerful support for quality research of isavuconazole sulfate. By controlling the two specific impurities, namely the RS isomer impurity and the quaternary ammonium salt impurity, in the production process, the product quality of isavuconazole sulfate and the stability of the medicine quality can be improved.

This invention relates to the field of pharmaceutical injection technology, specifically to a neostigmine methylsulfate injection and its preparation method. The preparation method of the neostigmine methylsulfate injection of this invention includes the following steps: S1 pretreatment of water for injection, S2 preparation, S3 filtration, S4 filling and sealing, and S5 sterilization. This invention features a simple process, high yield, and low cost. It effectively reduces the generation of impurity I in the neostigmine methylsulfate injection, improves the storage stability of the product, reduces potential medication safety hazards caused by impurities, and ensures drug quality and medication safety.

The invention relates to the technical field of informatization management, and discloses a medical drug informatization management system and method based on big data, and the method integrates the multi-dimensional data of transportation, production, storage, sales, quality detection and the like of drugs, and pays attention to the dynamic features and static features of the drugs during feature extraction operation. And through accurate feature selection and deep learning model training, the quality risk, the sales volume change trend, the expiration risk and the inventory change trend of the medicine are effectively analyzed, accurate and powerful data support is provided for decision support, and effective help is provided for subsequent adjustment of the sales strategy and the production plan of the medicine. Therefore, the circulation efficiency of the medicine is further improved, inventory overstock and overdue loss are reduced, the stability of the medicine quality is ensured, accurate management and risk control of the medicine can be realized in a continuously changing market environment, and the supply chain management level of the medicine is effectively improved.

The invention discloses an improved loading method of a nano-drug carrier, which comprises the following steps: adding a carrier of recombinant human heavy-chain ferritin or a derivative thereof into a high-concentration urea solution, mixing and reacting to depolymerize a shell of the recombinant human heavy-chain ferritin; adding a medicine, mixing and incubating; and diluting a reaction solution obtained by incubation into a low-concentration urea solution by using a Tris buffer solution, reacting for 8-15 hours to re-polymerize the recombinant human heavy chain ferritin shell, and finally changing the solution by using a membrane bag with the molecular weight cutoff of 50 KD through the Tris buffer solution to obtain the loaded ferritin drug composite particles. According to the preparation method provided by the invention, the effect of obviously improving the protein recovery rate and the drug loading capacity is achieved by providing a preparation method of replacing liquid after dilution and then standing and optimizing the drug-mass ratio, the protein recovery rate can reach 100%, and the drug loading capacity can reach 186 mu g / mL.

The application discloses a method for purifying and removing impurities from ranitidine base, which comprises the following steps: (1) dissolving ranitidine base; (2) removing water under reduced pressure to obtain a water content of less than 0.2 wt%; (3) crystallizing; and (4) filtering, washing and drying to obtain refined ranitidine base after removing impurities. The method for purifying and removing impurities from ranitidine base is characterized in that: first, non-polar solvent is used to dissolve and distill water; then, ranitidine base is extracted by crystallization; and finally, impurity A of ranitidine is retained in the non-polar solvent, so that impurity A in the ranitidine base is effectively removed, and the content of impurity A in the ranitidine base is reduced to below the limited requirement of drug quality control.

The invention provides a compound with a triphenylamine-triazine structure, a D-A type polytriphenylamine-triazine compound, preparation methods of the compound and the D-A type polytriphenylamine-triazine compound and application of the compound to drug detection and TNT content detection in a water body, and belongs to the technical field of drug quality detection and environment detection in the water body. The structural formula of the compound with the triphenylamine-triazine structure provided by the invention is as shown in the formula lt, igt; the structural formula of the D-A type polytriphenylamine triazine compound is as shown in the formula lt, iI < gt >; x is-SO2 <-> or-CO <->. The D-A type polytriphenylamine triazine compound has strong luminescence performance, can be well used for detection of drugs such as a salbutamol sulfate solution, and can also be used for detection of trace TNT. The extremely low detection limits on TNT (trinitrotoluene) are respectively 39 nM and 70 nM. Meanwhile, the fluorescent probe shows good anti-interference capability, and is almost not influenced by potential factors such as pH, other nitro compounds, metal cations and anions and the like. # imgabs0 #

The invention relates to a synchronous detection method for impurities contained in candesartan cilexetil and amlodipine besylate, which is suitable for quality control of compound preparations. According to the method, a high performance liquid chromatography technology is adopted, an octadecyl silane bonded silica gel column is used as a chromatographic column, gradient elution conditions are optimized, a water-acetonitrile-trifluoroacetic acid mixed solution is used as a mobile phase A, and an acetonitrile-water-trifluoroacetic acid mixed solution is used as a mobile phase B; according to the method, the impurity contents of amlodipine besylate and candesartan cilexetil are respectively detected under the wavelengths of 240 nm and 253 nm through gradient elution, the separation degree R value is greater than 1.5, the detection sensitivity is high, and the lower quantification limit reaches 0.05%. The method can simultaneously separate and quantify various process impurities and degradation impurities of candesartan cilexetil and amlodipine besylate in the compound preparation, and has the characteristics of high efficiency, accuracy and stability. The method is easy and convenient to operate, low in cost and suitable for compound preparation quality control under the industrial production condition, and scientific support can be provided for improving the medicine quality standard.

The present application relates to the technical field of warehousing logistics, and in particular to a big data-based cold chain logistics warehousing intelligent management system. The system comprises: acquiring and analyzing a loading plan, and determining drug information and warehouse information; analyzing the drug information to determine a suitable storage temperature; analyzing the drug information, the warehouse information, and the suitable storage temperature to determine a non-cold chain environment quality assurance time of a drug; determining vehicle information on the basis of the suitable storage temperature and the drug information; and on the basis of the drug information, the warehouse information, the vehicle information, and the non-cold chain environment quality assurance time, formulating a loading strategy for reference by the cold chain logistics warehousing staff. By comprehensively analyzing the drug information, the warehouse information, the vehicle information, etc., a scientific loading strategy is formulated, so as to improve cold chain logistics efficiency, ensure drug quality, optimize resource configuration, and provide decision support for the staff, thereby improving the customer satisfaction and the overall operational performance.

The invention belongs to the technical field of medicine synthesis, and particularly relates to a synthesis method of a suzertraline impurity, the process route is shown as the following reaction formula: S1, a compound I is subjected to double bond reduction to obtain a compound II; s2, carrying out carbonyl reduction on the compound II to obtain a compound III; s3, esterifying the compound III to obtain a compound IV; s4, performing nucleophilic substitution on the compound IV to obtain a compound V; s5, hydrolyzing the compound V to obtain a compound VI; and S6, carrying out condensation reaction on the compound VI and the compound VII to obtain an isomer impurity VIII. The invention discloses a synthesis route of the suzertraline isomer impurity VIII for the first time, solves the problem that the impurity lacks a standard reference substance in drug quality control, and provides a necessary material basis for quality research and analysis method development and verification of suzertraline bulk drugs and preparations.

The invention belongs to the technical field of biosensing detection, and particularly discloses a label-free ratio fluorescence sensor and application thereof in quinine detection. The label-free ratio fluorescent aptamer sensor takes isothiocyanate as an internal reference signal and a fluorescent dye as a detection signal, and is obtained by mixing and incubating a quinine specific nucleic acid aptamer, a triphenylmethane fluorescent dye and isothiocyanate in a buffer solution. According to the invention, isothiocyanate is introduced as an internal reference signal, triphenylmethane dye is selected as a target response fluorescence signal molecule, and the quinine is detected by using the obvious fluorescence change of the target response fluorescence signal molecule in the binding-dissociation process of the target response fluorescence signal molecule and a quinine specific nucleic acid aptamer. The label-free ratio fluorescence sensor has excellent selectivity and stability, can be widely applied to the fields of food safety supervision, drug quality control, environmental water quality detection and the like, and is particularly suitable for rapid detection and emergency monitoring of quinine under the condition of limited resources.

The utility model belongs to the technical field of pharmaceutical preparation production equipment, especially is with metering feeder for choline bitartrate tablet preparation, including sealed storage unit, sealed gas control unit, anti -blocking unit and metering conveying unit, sealed storage unit includes sealed storage tank, sealed gas control unit includes gas injection port, suction port and pressure gauge, anti -blocking unit includes the electromagnetic vibrator and linkage stirring subassembly that are established, metering conveying unit includes the feed pipe and screw conveying mechanism, the top surface one end of feed pipe is equipped with the material inlet nozzle, bottom surface other end is equipped with the material outlet nozzle, is equipped with solenoid valve and microwave solid flowmeter on the material inlet nozzle, replaces manual weighing feeding, has improved production efficiency, adapts to scale production, adopts inert atmosphere closed loop control, avoids raw material oxidation, guarantees raw material active ingredient and drug quality, whole sealed conveying path, no dust flying, avoids the risk of professional exposure of operating personnel simultaneously.

The present application relates to the technical field of data transmission, and discloses a radioactive drug synthesis data transmission method and system, which comprises the following steps: collecting drug synthesis data and data generation time, and obtaining a drug synthesis data sequence; determining the adjustment distance of two different kinds of drug synthesis data, and determining the data fluctuation influence of the target data generation time; determining a single difference kind and a single difference sequence, determining the synthesis drug quality influence degree of the single difference kind, determining the data outlier evaluation value of the current radioactive drug, dividing the drug synthesis data sequence of the current radioactive drug into sequence segments according to the data outlier evaluation value of the current radioactive drug; and encrypting the sequence segments to realize the transmission of the radioactive drug synthesis data. The present application can adjust the encryption security and transmission speed according to the storage requirements of the drug synthesis data.

The invention belongs to the field of medicine quality control, and particularly relates to a method for detecting N-nitroso-deethylidocaine genotoxic impurities in lidocaine. The method is realized by the following steps: firstly, preparing a test solution and a reference solution; and then, detecting by adopting a high performance liquid chromatography-triple quadrupole mass spectrometry method. The detection method provided by the invention can realize good quality control on lidocaine raw material medicines and preparations thereof, is strong in durability and high in detection sensitivity, can effectively avoid interference generated by a solvent, has a good impurity separation effect, can accurately detect toxic impurities in lidocaine, and is suitable for large-scale popularization and application. The method has the advantages of high sensitivity, strong specificity and good reproducibility. The detection method provided by the invention is simple and strong in operability.

The invention provides a medicine quality detection data processing analysis system and method, and the method comprises the steps: carrying out the time sequence alignment processing of original multi-source detection data, extracting a detection data fragment reflecting the quality attribute of a target medicine, and generating a characteristic evolution sequence of the quality of the target medicine between different batches according to the detection data fragment; screening out a plurality of difference sensitive features representing the batch stability of the target drug according to the feature evolution sequence, and converting all the difference sensitive features into inter-batch difference quantities of the target drug in the batch quality inspection process; generating a uniformity index of the quality in the target drug batch according to the dispersion of the quality data of different sample points in the same batch in the aligned multi-source detection data; and carrying out quality grade analysis on the target drugs of the current batch based on the inter-batch difference quantity and the uniformity index to obtain an analysis result. By adopting the scheme, the comprehensive analysis of the batch difference of the medicine quality can be realized in a batch quality inspection scene, so that the analysis error in the medicine quality monitoring process is reduced.

The invention provides an electron beam sterilization method of an implant, which is characterized in that the implant is irradiated by using a high-energy electron beam, the irradiation mode is at least twice, the irradiation dose of each time is not more than 20kGy, and the absorbed dose of the implant after irradiation is not less than 16kGy and not more than 50kGy. The method provided by the invention can ensure that the sterility level SAL is less than 10 <-6 >, can ensure that the drug quality of the implant is not affected, and can ensure that no new impurities are generated in the sterilization process.

The invention provides a method for separating and detecting components in butanedisulfonic acid ademetionine enteric-coated tablets, and belongs to the technical field of medicine quality analysis. According to the method, ammonium formate solution-water-acetonitrile and ammonium formate solution-acetonitrile-methyl tert-butyl ether are used as a mobile phase system, and the pH value of the ammonium formate solution is controlled to be 2.2-3.1, so that adenosine and adenine can be effectively separated; according to the method, the S-adenosyl-L-methionine glycine isomer 2, adenosine, adenine and S-adenosyl-L-homocysteine can be separated, the time consumption is short, the separation efficiency is high, the operation is simple, the separation cost is low, and the quality control of butanedisulfonic acid adenosyl methionine or related preparations can be improved. According to the method, the detection of the ademetionine and the related impurities is not influenced by auxiliary materials, the method is efficient and convenient, good in reproducibility, high in specificity, high in accuracy and high in sensitivity, and the quality control of the ademetionine sample can be realized.

The invention relates to the technical field of medical analysis, and particularly provides a method for determining the content of 1, 2-dichloroethane in a residual solvent of 4-cyano-2-methoxybenzaldehyde. The method comprises the following steps: 1) preparing a reference solution and a test solution; 2) setting headspace sampling conditions; 3) setting gas chromatographic analysis conditions, and separating 1, 2-dichloroethane from other impurities by using a capillary chromatographic column of 6% cyanopropyl phenyl-94% dimethyl polysiloxane and a carrier gas of nitrogen by using a heating program; and 3) respectively sucking the reference substance solution and the test solution, injecting into a gas chromatograph, and recording a chromatogram. The method disclosed by the invention can be used for rapidly, effectively, accurately and reliably detecting the content of the residual solvent 1, 2-dichloroethane of the 4-cyano-2-methoxybenzaldehyde so as to meet the requirements of drug quality control.

The invention discloses a method for determining the content of multiple components in a Sapococcum / Sapococcum mixture and application. The method comprises the steps of preparation of a test solution, preparation of a mixed reference solution, determination of chromatographic conditions, content determination and the like. According to the method for determining the content of the multiple components in the Sanyone mixture, the content of the eight components in the Sanyone mixture can be determined at the same time within 50 min through optimization of chromatographic conditions, the analysis and detection time is greatly shortened, waste of reagent testing reagents is avoided, energy consumption of equipment is reduced, and meanwhile, the detection efficiency is improved. According to the present invention, the multi-index components are determined, such that the overall quality condition of the preparation can be efficiently and comprehensively reflected, such that the drug quality control standard is substantially improved, the medication safety of the patient can be easily ensured, the drug quality can be easily improved, and the important value is provided for the quality control and improvement and the clinical promotion and application of the Sapococcum / Sapococcum mixture.

The invention discloses an LMTIA primer group for detecting a subprostrate sophora component, a detection method, a kit and application of the LMTIA primer group, and belongs to the technical field of molecular biology nucleic acid detection. The invention designs an LMTIA primer group for identifying the components of the subprostrate sophora, the LMTIA primer group comprises primers SdouG-1F1, SdouG-1B1, SdouG-1LF and SdouG-1LB, and a detection method for identifying the components of the subprostrate sophora is constructed on the basis of an LMTIA technology. The method is simple to operate, short in reaction time, high in sensitivity and strong in specificity. The minimum detection concentration of the vietnamese sophora root can reach 1pg / mu L, and the minimum detection limit content of the vietnamese sophora root is 0.1% for a mixed system containing other sample gene DNA (Deoxyribose Nucleic Acid). The detection method not only can specifically identify the true and false characteristics of the subprostrate sophora product, but also can effectively detect the subprostrate sophora component in the medicine matrix. The method is suitable for the fields of food and drug quality control, Chinese herbal medicine identification and market supervision.